Quotient Sciences Appoints Thierry Van Nieuwenhove as CEO
What We Do
Selecting the right molecules for development.
Accelerating molecules through to proof-of-concept.
Accelerating molecules through to commercial manufacture.
Integrated development platform, proven to reduce timelines.
Clinical trial supplies for oral, injectable, & inhaled dosage forms.
Phase I healthy volunteer studies & 14C Human ADME.
Tech transfer, process scale-up & optimization, & lifecycle management.
PR&D, custom synthesis, & drug substance characterization.
Simple & complex dosage forms: PIB, PIC, tablets, poorly soluble, modified-release, pediatrics.
Rapid bioanalytical data in discovery, pre-clinical & clinical.
Rapid access to clinical data & results to accelerate drug development.
Holistic scientific advice at each stage of drug development.